Lihua Xing
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Molecular Medicine top 10%
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 3
-
- Intensive Care Unit Cognitive Disorders 4
-
- Respiratory Support and Mechanisms 5
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
-
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Co-authors
- Mengying YaoWentao MaBing CuiWeihong ZhangQiuhong LiuJing GaoWei‐Hong ZhangMing Zhang
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lihua Xing
34 papers receiving 671 citations
Peers
Comparison fields: 5 of 92
- Applied Microbiology and Biotechnology 28
- Cancer Research 142
- Molecular Medicine 44
- Infectious Diseases 154
- Critical Care and Intensive Care Medicine 31
Countries citing papers authored by Lihua Xing
This map shows the geographic impact of Lihua Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihua Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihua Xing more than expected).
Fields of papers citing papers by Lihua Xing
This network shows the impact of papers produced by Lihua Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihua Xing. The network helps show where Lihua Xing may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lihua Xing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 6 | |
| 5 | 2022 | 16 | |
| 6 | 2022 | 22 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 16 | |
| 9 | 2022 | 17 | |
| 10 | 2021 | 44 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 2 | |
| 13 | 2021 | 10 | |
| 14 | 2020 | 139 | |
| 15 | 2020 | 27 | |
| 16 | 2019 | 85 | |
| 17 | 2019 | 10 | |
| 18 | 2017 | 2 | |
| 19 | 2007 | 1 | |
| 20 | 2006 | 6 |
About Lihua Xing
Lihua Xing is a scholar working on Critical Care and Intensive Care Medicine, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 35 papers that have together received 676 indexed citations. Recurring topics across this work include Respiratory Support and Mechanisms (5 papers), COVID-19 Clinical Research Studies (4 papers), Intensive Care Unit Cognitive Disorders (4 papers), Cancer-related molecular mechanisms research (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), MicroRNA in disease regulation (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (28 citations), Cancer Research (142 citations) and Molecular Medicine (44 citations). Lihua Xing has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Mengying Yao, Wentao Ma, Bing Cui, Weihong Zhang, Qiuhong Liu, Jing Gao, Wei‐Hong Zhang, Ming Zhang, Jin Shang and Peng Zhou. Their work appears in journals such as Bioinformatics, PLoS ONE and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.